As a subclass of type I IFNs, IFN-β directly inhibits tumor cell proliferation and survival while mobilizing systemic immune responses through enhanced antigen presentation, natural killer (NK) cell activation, and T-cell effector function [9–11]. Here, IFNB1 is linked to neoplasm.